Fact CheckerSign in

NCT06029686Not yet recruiting

Vibrotactile Coordinated Reset for Parkinson's Patients of a More Variable Population

Source: ClinicalTrials.gov · Last updated 19 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms of a more variable population. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and or deep brain stimulation. Patients will be followed for two years.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
1 Sept 2023
Start date
1 May 2025
Primary completion date
31 Dec 2026
Lead sponsor
Stanford University
NCT number
NCT06029686

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 1 May 2025 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any current drug or alcohol abuse.
  • Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  • Brain surgery
  • Patient is taking a medication that may cause significant withdrawal effects

Other illness

  • Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies

Other

  • Pregnancy, breast-feeding or wanting to become pregnant
  • Craniotomy
  • Patient is unable to communicate properly with staff (i.e., severe speech problems)
  • Excessive drooling

Who the study is looking for

  • Age at the time of enrollment: 35 - 92 years
  • Idiopathic Parkinson's Symptoms between Hoehn and Yahr stages 2 to
  • Fluent in English
  • Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
  • Feels comfortable going off PD related medication during in person study visits
  • Lives in the United States

Age in the registry: 35 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford University
Coordinator of this site? Confirm its status
StanfordUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.